Reviews and feature articlePathogenic mechanisms of B-lymphocyte dysfunction in HIV disease
Section snippets
B-cell hyperactivation in HIV disease
Many features of B-cell dysregulation in HIV disease suggest a prominent role for aberrant immune activation. These features include elevated serum levels of immunoglobulins and autoantibodies,6 extensive expansion in B-cell areas of lymphoid tissue,7, 8 and an increased expression of activation, proliferation, and terminal differentiation markers on circulating B cells.5, 9, 10, 11 As illustrated in Fig 1 and in data not shown, terminal differentiation of B cells is associated with a loss in
Direct interactions between HIV and B cells
Although there is little evidence that HIV productively infects B cells in vivo, we have shown that B cells isolated from the blood and lymph nodes of HIV-infected individuals carry replication-competent virus on their surface.21 The interaction is mediated primarily through the binding of complement-opsonized HIV virions to CD21 expressed on the surface of B cells. These findings are consistent with other in vivo and in vitro studies demonstrating a prominent role for CD21 in the trapping of
Changes in B-cell subpopulations in HIV disease
Many of the B-cell aberrations that have been reported in HIV disease are likely to reflect alterations in the frequencies of the various subpopulations of B cells that are present in the human body, or at least that are detectable in the peripheral blood (Table I). Given that the vast majority of these studies have been performed on B cells isolated from the peripheral blood, we restrict our comments to alterations in this compartment. Naive B cells constitute the largest B-cell subpopulation
Increased B-cell death in HIV disease
Cell death by apoptosis is an important component of immune activation and lymphocyte depletion in HIV disease.46 Two major pathways of apoptosis exist: the intrinsic pathway arises from an insufficiency in survival factors that result in mitochondrial-driven apoptosis, whereas the extrinsic pathway arises from the triggering of a death receptor.47 In HIV disease, both these pathways likely contribute to increased B-cell death,18, 48 and B-cell depletion that we and others have documented.35, 49
Functional alterations of B cells in HIV disease
The effects of HIV infection on B-cell function can be divided into 2 broad categories. The first category relates to changes that directly reflect in vivo phenomena, such as hypergammaglobulinemia, increased autoantibody levels, and poor antibody responses to specific antigens. The second category relates to changes that are inferred from ex vivo analysis of B cells isolated from HIV-infected individuals. There have been substantial advances in the latter category over the period of the past
Conclusion
In summary, HIV infection in a majority of untreated individuals leads to persistent viral replication and progressive CD4+ T-cell lymphopenia. Persistent HIV replication is associated with increased immune activation that manifests itself in the B-cell compartment as hypergammaglobulinemia, polyclonal B-cell activation, induction of terminal differentiation of B cells, increased levels of autoantibodies, and increased frequency of B-cell malignancies. CD4+ T cell lymphopenia and increased
References (80)
- et al.
Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects: monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cells
Clin Immunol
(2002) - et al.
Role of complement in the control of HIV dynamics and pathogenesis
Vaccine
(2003) Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex
Curr Opin Immunol
(2005)- et al.
Antibodies and B cell memory in viral immunity
Immunity
(2007) - et al.
Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis
Clin Immunol
(2001) - et al.
Identification and characterization of circulating human transitional B cells
Blood
(2005) - et al.
Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7
Blood
(2007) - et al.
A potential role for interleukin-7 in T-cell homeostasis
Blood
(2001) - et al.
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART)
Blood
(2000) - et al.
Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection
Blood
(2006)
Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group
J Allergy Clin Immunol
The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease
Lancet Infect Dis
Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children
Lancet Infect Dis
B lymphocyte dysfunctions in HIV infection
Curr HIV Res
NK cells in HIV infection: paradigm for protection or targets for ambush
Nat Rev Immunol
Pathogenesis of HIV infection: what the virus spares is as important as what it destroys
Nat Med
Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection
PLoS Biol
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome
N Engl J Med
B-lymphocytes and autoantibody profiles in HIV disease
Clin Rev Allergy Immunol
Lymphatic tissue changes in AIDS and other retrovirus infections: tools and insights
Lymphology
Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection
Immunol Rev
HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals
Proc Natl Acad Sci U S A
Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation
J Clin Invest
B-cell activation and lymphoma in patients with HIV
Curr Opin Oncol
Downregulation of CXCR5 in CD27- B cells of HIV-1 infected patients
J Med Virol
Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function
J Acquir Immune Defic Syndr
Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy
Gut
Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses
AIDS Res Hum Retroviruses
HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy
J Exp Med
Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily
J Exp Med
Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study
Nat Med
Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7
Proc Natl Acad Sci U S A
B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells
J Exp Med
Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasma
J Virol
Immunoglobulin VH3 gene products: natural ligands for HIV gp120
Science
Selective alterations of the antibody response to HIV-1
Appl Biochem Biotechnol
Impact of HIV-1 infection on VH3 gene repertoire of naive human B cells
J Immunol
Immunoglobulin V(H) usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses
J Virol
Loss of memory (CD27) B lymphocytes in HIV-1 infection
AIDS
Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage
J Immunol
Cited by (0)
(Supported by an educational grant from Merck & Co., Inc.)
Series editors: Joshua A. Boyce, MD, Fred Finkelman, MD, William T. Shearer, MD, PhD, and Donata Vercelli, MD
Terms in boldface and italics are defined in the glossary on page 13.